Public consultations on applications for authorisation
Public consultations are launched on the ECHA Website related to alternative substances or technologies on eight applications for authorisation covering 10 uses of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated. The substance is used to produce various medical devices and medicinal/biopharmaceuticals.
The deadline for comments is 8 April 2020.